AMPK-Dependent Metabolic Regulation by PPAR Agonists

AMPK-Dependent Metabolic Regulation by PPAR Agonists

Comprehensive studies support the notion that the peroxisome proliferator-activated receptors, (PPARs), PPARα, PPARβ/δ, and PPARγ, regulate cell growth, morphogenesis, differentiation, and homeostasis. Agonists of each PPAR subtype exert their effects similarly or distinctly in different tissues suc...

Full description

Saved in:

Bibliographic Details
Main Authors:	Woo Hyung Lee, Sang Geon Kim
Format:	Article
Language:	English
Published:	Wiley 2010-01-01
Series:	PPAR Research
Online Access:	http://dx.doi.org/10.1155/2010/549101
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Hypothalamic AMPK as a Regulator of Energy Homeostasis
by: My Khanh Q. Huynh, et al.
Published: (2016-01-01)

Regulation of Glial Cell Functions by PPAR-𝜸 Natural and Synthetic Agonists
by: Antonietta Bernardo, et al.
Published: (2008-01-01)

PPAR Agonists and Cardiovascular Disease in Diabetes
by: Anna C. Calkin, et al.
Published: (2008-01-01)

The PPAR Gamma Agonist Troglitazone Regulates Erk 1/2 Phosphorylation via a PPARγ-Independent, MEK-Dependent Pathway in Human Prostate Cancer Cells
by: Adrienne Bolden, et al.
Published: (2012-01-01)

Cannabinoids: A New Group of Agonists of PPARs
by: Yan Sun, et al.
Published: (2007-01-01)

PPAR Agonists for the Prevention and Treatment of Lung Cancer
by: Sowmya P. Lakshmi, et al.
Published: (2017-01-01)

Effects of the PPARα Agonist and Widely Used Antihyperlipidemic Drug Gemfibrozil on Hepatic Toxicity and Lipid Metabolism
by: Michael L. Cunningham, et al.
Published: (2010-01-01)

PPARα-Independent Arterial Smooth Muscle Relaxant Effects of PPARα Agonists
by: Neerupma Silswal, et al.
Published: (2012-01-01)

Role of PPARα and Its Agonist in Renal Diseases
by: Ching-Feng Cheng, et al.
Published: (2010-01-01)

The Role of PPARγ in the Transcriptional Control by Agonists and Antagonists
by: Tamotsu Tsukahara
Published: (2012-01-01)

PPARγ and Its Agonists in Chronic Kidney Disease
by: Yuhua Ma, et al.
Published: (2020-01-01)

PPAR-γ Agonists and Their Role in Primary Cicatricial Alopecia
by: Sarawin Harnchoowong, et al.
Published: (2017-01-01)

Inhibition of Carrageenan-Induced Cutaneous Inflammation by PPAR Agonists Is Dependent on Hepatocyte-Specific Retinoid X Receptor Alpha
by: Yu-Jui Yvonne Wan, et al.
Published: (2006-01-01)

New Insights into the PPARγ Agonists for the Treatment of Diabetic Nephropathy
by: Zhanjun Jia, et al.
Published: (2014-01-01)

The Case for the Use of PPARγ Agonists as an Adjunctive Therapy for Cerebral Malaria
by: Lena Serghides
Published: (2012-01-01)

PPARs and Metabolic Syndrome
by: Lihong Chen, et al.
Published: (2014-01-01)

2D-QSAR Analysis of Oxadiazole Substituted α-Isopropoxy phenylpropionic Acids as PPAR-α & PPAR-λ Agonists
by: Soni L. K., et al.
Published: (2004-01-01)

PPAR-γ Agonists and Their Effects on IGF-I Receptor Signaling: Implications for Cancer
by: A. Belfiore, et al.
Published: (2009-01-01)

Do PPAR-Gamma Agonists Have a Future in Parkinson's Disease Therapy?
by: Anna R. Carta, et al.
Published: (2011-01-01)

Anticancer Role of PPARγ Agonists in Hematological Malignancies Found in the Vasculature, Marrow, and Eyes
by: P. J. Simpson-Haidaris, et al.
Published: (2010-01-01)

Protective Effect of PPARγ Agonists on Cerebellar Tissues Oxidative Damage in Hypothyroid Rats
by: Yousef Baghcheghi, et al.
Published: (2016-01-01)

PPAR-Alpha Agonist Fenofibrate Combined with Octreotide Acetate in the Treatment of Acute Hyperlipidemia Pancreatitis
by: Wen Bao, et al.
Published: (2021-01-01)

Possible Role of Interaction between PPARα and Cyclophilin D in Cardioprotection of AMPK against In Vivo Ischemia-Reperfusion in Rats
by: Giselle Barreto-Torres, et al.
Published: (2016-01-01)

Kaempferol improves glucose uptake in skeletal muscle via an AMPK-dependent mechanism
by: William T. Moore, et al.
Published: (2023-11-01)

Rosiglitazone Restores Endothelial Dysfunction in a Rat Model of Metabolic Syndrome through PPARγ- and PPARδ-Dependent Phosphorylation of Akt and eNOS
by: Zhigang Zhao, et al.
Published: (2011-01-01)

Retracted: Possible Role of Interaction between PPARα and Cyclophilin D in Cardioprotection of AMPK against In Vivo Ischemia-Reperfusion in Rats
by: PPAR Research
Published: (2019-01-01)

Combination PPARγ and RXR Agonist Treatment in Melanoma Cells: Functional Importance of S100A2
by: Joshua P. Klopper, et al.
Published: (2010-01-01)

PPAR-α Agonist Fenofibrate Decreased Serum Irisin Levels in Type 2 Diabetes Patients with Hypertriglyceridemia
by: Xiaomeng Feng, et al.
Published: (2015-01-01)

The PPARγ Agonist Rosiglitazone Is Antifibrotic for Scleroderma Lung Fibroblasts: Mechanisms of Action and Differential Racial Effects
by: Galina S. Bogatkevich, et al.
Published: (2012-01-01)

PPARs Integrate the Mammalian Clock and Energy Metabolism
by: Lihong Chen, et al.
Published: (2014-01-01)

Positive feedback loop involving AMPK and CLYBL acetylation links metabolic rewiring and inflammatory responses
by: Wenke Wang, et al.
Published: (2025-01-01)

Coactivators in PPAR-Regulated Gene Expression
by: Navin Viswakarma, et al.
Published: (2010-01-01)

Combined Effects of PPARγ Agonists and Epidermal Growth Factor Receptor Inhibitors in Human Proximal Tubule Cells
by: Katherine Pegg, et al.
Published: (2013-01-01)

The Roles of PPARs in the Fetal Origins of Metabolic Health and Disease
by: William D. Rees, et al.
Published: (2008-01-01)

Various Terpenoids Derived from Herbal and Dietary Plants Function as PPAR Modulators and Regulate Carbohydrate and Lipid Metabolism
by: Tsuyoshi Goto, et al.
Published: (2010-01-01)

PPAR-α regulates metabolic remodelling and participates in myocardial fibrosis in patients with atrial fibrillation of rheumatic heart disease
by: Xiaoying Hu, et al.
Published: (2024-07-01)

Clonazepam as Agonist Substitution Treatment for Benzodiazepine Dependence: A Case Report
by: Angelo Giovanni Icro Maremmani, et al.
Published: (2013-01-01)

Antioxidant Potential of Adiponectin and Full PPAR-γ Agonist in Correcting Streptozotocin-Induced Vascular Abnormality in Spontaneously Hypertensive Rats
by: Sheryar Afzal, et al.
Published: (2021-01-01)

PPARγ Agonist Rosiglitazone Suppresses Renal mPGES-1/PGE2 Pathway in db/db Mice
by: Ying Sun, et al.
Published: (2013-01-01)

Targeting TCMR-associated cytokine genes for drug screening identifies PPARγ agonists as novel immunomodulatory agents in transplantation
by: Lu Hu, et al.
Published: (2025-01-01)